Cipher Pharmaceuticals Inc. (TSX:CPH)

Canada · Delayed Price · Currency is CAD

17.99

+0.44 (2.51%)

Aug 10, 2026, 3:59 PM EST

Cipher Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	50.94	50.45	33.36	21.16	20.68	21.94
Revenue Growth	28.90%	51.22%	57.66%	2.36%	-5.78%	1.55%
Gross Profit	41.58	40.42	24.1	17.09	16.68	18.26
Operating Income	19.82	16.51	5.13	10.03	11.05	11.81
Net Income	30.87	27.2	11.55	20.38	26.64	7.76
Earnings Per Share	1.18	1.05	0.46	0.80	1.03	0.29
EPS Growth	227.78%	128.26%	-42.50%	-22.33%	255.17%	81.25%

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Canada	16.8	16.91	14.79	12.68	12.41	11.41
United States (U.S.)	34.14	33.54	18.57	8.48	8.27	10.53
Total	50.94	50.45	33.36	21.16	20.68	21.94

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	6.41	7.49	17.84	39.83	28.84	20.55
Total Debt	0.43	5.51	40.58	0.35	0.43	0.52
Net Cash (Debt)	5.98	1.99	-22.74	39.47	28.41	20.03
Net Cash Growth	-	-	-	38.95%	41.81%	174.67%
Net Cash Per Share	0.23	0.08	-0.90	1.55	1.10	0.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	30.03	29.73	19.55	16	10.73	13.81
Capital Expenditures	-0.03	-0.03	-0.04	-0.02	-0.08	-
Free Cash Flow	30	29.7	19.5	15.98	10.64	13.81
Free Cash Flow Growth	40.90%	52.28%	22.05%	50.11%	-22.95%	18.26%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	81.63%	80.12%	72.24%	80.77%	80.69%	83.21%
Operating Margin	38.91%	32.73%	15.39%	47.41%	53.45%	53.82%
Pretax Margin	39.71%	33.76%	8.86%	59.92%	55.52%	50.40%
Profit Margin	60.60%	53.91%	34.60%	96.32%	128.83%	35.36%
FCF Margin	58.90%	58.87%	58.45%	75.50%	51.48%	62.95%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	10.56	10.45	21.69	5.22	2.75	4.83
Forward PE	13.90	18.41	15.93	11.11	8.77	3.95
P/FCF Ratio	10.66	9.42	12.65	6.27	6.66	2.63
PS Ratio	6.28	5.54	7.39	4.73	3.43	1.66